shutterstock_742599325_testing
testing / Shutterstock.com
3 March 2020Big PharmaSarah Morgan

Thermo Fisher to buy Qiagen for $11.5bn

Biotech Thermo Fisher Scientific has announced plans to acquire Dutch diagnostics group Qiagen for $11.5 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
26 March 2019   Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.

More on this story

Americas
26 March 2019   Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.

More on this story

Americas
26 March 2019   Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.